Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for 10x Genomics (TXG : NSDQ)
 
 • Company Description   
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

Number of Employees: 410

 
 • Price / Volume Information   
Yesterday's Closing Price: $13.01 Daily Weekly Monthly
20 Day Moving Average: 4,184,147 shares
Shares Outstanding: 123.13 (millions)
Market Capitalization: $1,601.97 (millions)
Beta: 2.03
52 Week High: $24.76
52 Week Low: $6.78
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 38.11% 31.97%
12 Week 62.42% 38.73%
Year To Date -9.40% -15.14%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
6230 STONERIDGE MALL ROAD
-
PLEASANTON,CA 94588
USA
ph: 925-401-7300
fax: -
investors@10xgenomics.com http://www.10xgenomics.com
 
 • General Corporate Information   
Officers
Serge Saxonov - Chief Executive Officer and Director
John R. Stuelpnagel - Chairman
Benjamin J. Hindson - President
Adam S. Taich - Chief Financial Officer
Sridhar Kosaraju - Director

Peer Information
10x Genomics (HLIS)
10x Genomics (AZTA)
10x Genomics (APYI)
10x Genomics (RNVA)
10x Genomics (HMSY)
10x Genomics (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 88025U109
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
Share - Related Items
Shares Outstanding: 123.13
Most Recent Split Date: (:1)
Beta: 2.03
Market Capitalization: $1,601.97 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.27 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.20 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 25.05% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/14/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.25
Price/Cash Flow: -
Price / Sales: 2.56
EPS Growth
vs. Year Ago Period: 28.00%
vs. Previous Quarter: 10.00%
Sales Growth
vs. Year Ago Period: 9.84%
vs. Previous Quarter: -6.14%
ROE
06/30/25 - -
03/31/25 - -23.22
12/31/24 - -25.40
ROA
06/30/25 - -
03/31/25 - -18.02
12/31/24 - -19.69
Current Ratio
06/30/25 - -
03/31/25 - 5.37
12/31/24 - 4.97
Quick Ratio
06/30/25 - -
03/31/25 - 4.68
12/31/24 - 4.26
Operating Margin
06/30/25 - -
03/31/25 - -26.61
12/31/24 - -29.90
Net Margin
06/30/25 - -
03/31/25 - -25.14
12/31/24 - -29.90
Pre-Tax Margin
06/30/25 - -
03/31/25 - -24.56
12/31/24 - -29.09
Book Value
06/30/25 - -
03/31/25 - 5.78
12/31/24 - 5.81
Inventory Turnover
06/30/25 - -
03/31/25 - 2.32
12/31/24 - 2.25
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©